<?xml version="1.0" encoding="UTF-8"?>
<ref id="B67-pharmaceuticals-13-00464">
 <label>67.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>He</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Tang</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Andersson</surname>
    <given-names>E.I.</given-names>
   </name>
   <name>
    <surname>Timonen</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Koschmieder</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Wennerberg</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Mustjoki</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Aittokallio</surname>
    <given-names>T.</given-names>
   </name>
  </person-group>
  <article-title>Patient-Customized Drug Combination Prediction and Testing for T-cell Prolymphocytic Leukemia Patients</article-title>
  <source>Cancer Res.</source>
  <year>2018</year>
  <volume>78</volume>
  <fpage>2407</fpage>
  <lpage>2418</lpage>
  <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-17-3644</pub-id>
  <pub-id pub-id-type="pmid">29483097</pub-id>
 </element-citation>
</ref>
